Results 151 to 160 of about 90,526 (229)

Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study. [PDF]

Hum Vaccin Immunother
Leroux-Roels I, De Coster I, Borobia AM, Langley JM, Ochoa Mazarro D, Ruiz-Antorán B, Berrè S, Germain S, Knauer C, Koch SD, Mann P, Mesia Vela D, Ovbude LJ, Pardo IA, Srivastava B, Moldt B, Nordgren M.   +16 more
europepmc   +1 more source

Comparison of safety and immunogenicity between high-dose and low-dose quadrivalent influenza vaccines in children aged 6-35 months in China: A randomized, double-blind clinical study. [PDF]

Hum Vaccin Immunother
Guo X, Li J, Dong X, Xing K, Xu X, Xu W, Wang C, Li K, Gao X, Qiu Y, Guo Z, Xu W, Zhao C, Ma Y, Wu Y, Liu X, Li G.   +16 more
europepmc   +1 more source

Effect of pH on small-molecule inhibitor binding to influenza virus hemagglutinin. [PDF]

J Biol Chem
Anirudhan V, Gaisina I, Shimon A, Lee H, Alqarni S, Manicassamy B, Moore TW, Xu K, Caffrey M, Rong L.   +9 more
europepmc   +1 more source

A Naked Lyophilized mRNA Vaccine Against Seasonal Influenza, Administered by Jet Injection, Provides a Robust Response in Immunized Mice. [PDF]

Vaccines (Basel)
Sharabrin SV, Krasnikova SI, Kisakov DN, Borgoyakova MB, Yakovlev VA, Tigeeva EV, Starostina EV, Litvinova VR, Kisakova LA, Vahitov DI, Makarova KP, Volosnikova EA, Ivanova KI, Bondar AA, Rudometova NB, Rudometov AP, Ilyichev AA, Karpenko LI.   +17 more
europepmc   +1 more source

A dual-adjuvanted HA stem nanoparticle vaccine elicits a multifunctional antibody response that is associated with protection in newborn monkeys. [PDF]

Cell Rep Med
Crofts KF, Holbrook BC, Page CL, Hendrix CJ, Caudell D, Gillespie RA, D'Agostino RB, Moin SM, Sangesland M, Ornelles DA, Kanekiyo M, Alexander-Miller MA.   +11 more
europepmc   +1 more source

Antibody Recognition of Highly and Low-Pathogenic A/H5Nx Influenza Viruses in Sera of Mexican Donors. [PDF]

Pathogens
Cordero-Ortiz M, Solís-Hernández M, Cayetano-Mondragón M, Guzmán NC, Valenzuela O, Mata-Haro V, Giménez-Lirola LG, Hernández J.   +7 more
europepmc   +1 more source

Correction to "Novel Epidemiologic Features of High Pathogenicity Avian Influenza Virus A H5N1 2.3.3.4b Panzootic: A Review". [PDF]

Transbound Emerg Dis
europepmc   +1 more source

Antigen flexibility supports the avidity of hemagglutinin-specific antibodies at low antigen densities. [PDF]

PLoS Pathog
Benegal A, He Y, Ho K, Groff G, Guo Z, Vahey MD.   +5 more
europepmc   +1 more source

Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins. [PDF]

Proc Natl Acad Sci U S A
Kadam RU, Juraszek J, Brandenburg B, Garg D, Zhu X, Jongeneelen M, Tang C, Schepens WBG, Buyck C, Stoops B, Vermond J, Vogels R, Friesen RHE, van Dongen MJP, Wilson IA.   +14 more
europepmc   +1 more source

Molecular and antigenic characteristics of the influenza B virus in Guangzhou, 2022-2023. [PDF]

Virol J
Liu Y, Wu S, Liu Y, Chen J, Xiao J, Zhang J, Huang Q, Pan W, Lin D, Wang Y, Chitin H, Yang Z, Deng X.   +12 more
europepmc   +1 more source